Comments*

 
  • Academy Events

  • Genome Integrity Discussion Group Meeting

    Monday, October 5, 2015 | 1:30 PM - 5:30 PM

    Speakers: Roger Greenberg (University of Pennsylvania), Andreas Hochwagen (New York University), Megan King (Yale University), Rodney Rothstein (Columbia University)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Plan Ahead

  • All Events 

    Topics:








    Browse Events from:
    to  

    Location:

    Wednesday, September 16, 2015 | 8:00 AM - 2:15 PM

    From Tumor Suppressors to Oncogenic Dynamics: The 2015 Dr. Paul Janssen Award Symposium

    Award Winner Bert Vogelstein (Johns Hopkins School of Medicine; Howard Hughes Medical Institute)

    This symposium will honor Dr. Bert Vogelstein, the recipient of the 2015 Dr. Paul Janssen Award for Biomedical Research, in recognition of his role in characterizing the underlying mechanisms of cancer. Symposium registration is free. Advance registration is required.

    Thursday, September 17, 2015 | 6:30 PM - 7:30 PM

    197th Annual Meeting of the New York Academy of Sciences

    Featuring: Mr. Ellis Rubinstein (NYAS Chief Executive Officer) and selected members of the Academy's Senior Staff

    Please join us for the Academy’s 197th Annual Members Meeting, followed by a Welcome Reception in honor of our new Members. Learn about how your Academy is evolving to meet the many challenges ahead, then meet and mingle with fellow Academy Members.

    Friday, September 18, 2015 | 8:30 AM - 4:30 PM

    Alzheimer's Disease and Tau: Pathogenic Mechanisms and Therapeutic Approaches

    Speakers: George S. Bloom (University of Virginia), Peter Davies (Feinstein Institute for Medical Research), Marc I. Diamond (University of Texas Southwestern Medical Center), Michael Hutton (Eli Lilly and Company), Khalid Iqbal (New York State Institute for Basic Research in Developmental Disabilities), Hartmuth C. Kolb (Johnson & Johnson, Janssen R&D), Nicole Leclerc (Université de Montréal), Kun Ping Lu (Harvard Medical School), Richard M. Ransohoff (Biogen)

    Speakers at this symposium will address novel tau-centered mechanisms of neurodegeneration and new therapeutic approaches for many devastating neurological disorders.

    Tuesday, September 29, 2015 | 12:00 PM - 5:00 PM

    Visualizing Cellular Messengers

    Speakers: Samie R. Jaffrey (Weill Cornell Medical College), Amy E. Palmer (University of Colorado)

    This symposium features state of the art chemical tools and imaging strategies for metal ions, redox signaling species, and metabolites in the cell, cellular delivery and targeting approaches, and their application to studying life processes.

    September 30 - October 1, 2015

    Mobile Health: The Power of Wearables, Sensors, and Apps to Transform Clinical Trials

    Keynote Speakers: Christian Stammel (Wearable Technologies AG), Ajay Verma (Biogen Idec)
    Speakers: Pam Baker (FierceBigData), Brian Bot (Sage Bionetworks), Glen de Vries (Medidata), John Hixson (University of California at San Francisco), Julian Jenkins (GlaxoSmithKline), David C. Magnus (Stanford Center for Biomedical Ethics), Linda Malek (Moses and Singer, LLP), John Mastrototaro (Medtronic), Veena Misra (The NSF Nanosystems Engineering Research Center (NERC) for Advanced Self-Powered Systems of Integrated Sensors and Technologies (ASSIST) and North Carolina State University), Bernard Munos (FasterCures [a center of the Milken Institute]), Fiorenzo Omenetto (Tufts University), Aydogan Ozcan (UCLA and the Howard Hughes Medical Institute), Tomasz Sablinski (Transparency Life Sciences), Leonard Sacks (US Food and Drug Administration), Pei Wang (Icahn School of Medicine at Mount Sinai)

    Continuous health monitoring using wearable sensors, mobile devices, and apps is becoming a powerful tool for assessing critical physiological parameters. The vast accumulation of real-time biometric data obtained from these technologies may hold invaluable clues for treating some of the most devastating human diseases.

    Monday, October 5, 2015 | 1:30 PM - 5:30 PM

    Genome Integrity Discussion Group Meeting

    Speakers: Roger Greenberg (University of Pennsylvania), Andreas Hochwagen (New York University), Megan King (Yale University), Rodney Rothstein (Columbia University)

    The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.

    Thursday, October 15, 2015 | 8:00 AM - 5:00 PM

    Advances in Human Microbiome Science

    Speakers: Jonathan Braun (University of CaliforniaLos Angeles), Rudolph Clerval (Enterome), David N. Cook (Seres Health), Stanislav Dusko Ehrlich (King's College London), Michael A. Fischbach (University of California, San Francisco), Andrew Goodman (Yale School of Medicine), Sarkis Mazmanian (California Institute of Technology), Paul O'Toole (University College Cork), R. Balfour Sartor (University of North Carolina School of Medicine)

    In the human colon, the microbiome forms one of the densest bacterial ecosystems known in nature. This symposium will highlight recent research innovations and therapeutic applications from the microbiome with a focus on gut health.

    Friday, October 16, 2015 | 8:30 AM - 5:00 PM

    Towards Evidence-based Nutrition and Obesity Policy: Methods, Implementation, and Political Reality

    Keynote Speakers: Sonia Angell (New York City Department of Health and Mental Hygiene), Rogan Kersh (Wake Forest University)
    Speakers: Eliza Barclay (NPR's Salt), Sanjay Basu (Stanford University), Julia Belluz (VOX), Jason P. Block (Harvard Medical School), Juan Rivera Dommarco (Research Center in Nutrition and Health, National Institutes of Public Health, Mexico), Helena Bottemiller Evich (Politico), Matthew Harding (Duke University), Terry Huang (CUNY School of Public Health), Nancy Huehnergarth (Nancy F. Huehnergarth Consulting), Barbara A. Laraia (Berkeley School of Public Health), Jeff Niederdeppe (Cornell University)

    Well-informed nutrition policy decisions which consider scientific evidence should strive for effective policies that improve health outcomes on a large scale. This one-day conference will focus on emerging research methodology, how to interpret research outcomes and how these can be used to inform policy.

    October 18 - 22, 2015

    Tenth Cooley's Anemia Symposium

    Keynote Speakers: Maria Domenica Cappellini (University of Milan) and Stuart H. Orkin (Boston Children's Hospital and Dana-Farber Cancer Institute)
    Speakers: Emanuele Angelucci (Cancer Hospital "Armando Businco," Cagliari), Jodie L. Babitt (Massachusetts General Hospital), Jonathan M. Barasch (Columbia University), Daniel E. Bauer (Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School), Sunil Bhandari (Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School), Caterina Borgna-Pignatti (University of Ferrara), Farid Boulad (Memorial Sloan-Kettering Cancer Center), Marina Cavazzana-Calvo (Hospital Necker, University Paris Descartes), David H.K. Chui (Boston University School of Medicine), Thomas D. Coates (Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine), Ann Dean (National Institutes of Health), David Dinan (Nemours Children’s Hospital), Alexander (Hal) Drakesmith (Radcliffe Department of Medicine, University of Oxford), Kathleen Durst (Cooley's Anemia Foundation), Giuliana Ferrari (San Raffaele-Telethon Institute for Gene Therapy), Steven Flamm (Northwestern Medical Center), Mark D. Fleming (Boston Children's Hospital), Ellen B. Fung (UCSF Benioff Children's Hospital Oakland), Andrea Giusti (Galliera Hospital), Olivier Hermine (Hospital Necker, University Paris Descartes), Doug Higgs (University of Oxford), Eldad Arie Hod (Columbia University), Janet L. Kwiatkowski (The Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania), Ashutosh (Ash) Lal (University of California San Francisco Benioff Children’s Hospital Oakland), Roberto Machado (University of Illinois College of Medicine), Takahiro Maeda (Harvard Cancer Center), Punam Malik (Cincinnati Children’s Hospital), Jeffery L. Miller (National Institute of Diabetes and Digestive and Kidney Diseases), David G. Nathan (Dana-Farber Cancer Institute), Elizabeth (Ella) Nemeth (University of California, Los Angeles), Ellis Neufeld (Boston Children's Hospital), Arthur Nienhuis (St. Jude Children's Research Hospital), Dudley Pennell (Imperial College London), Antonio Piga (Torino University), John Porter (University College London Hospitals), Scott Reeder (University of Wisconsin School of Medicine and Public Health), Stefano Rivella (Children's Hospital of Philadelphia), Thomas M. Ryan (The University of Alabama at Birmingham), Vijay Sankaran (Boston Children's Hospital and Dana-Farber Cancer Institute), Shalini Shenoy (St. Louis Children's Hospital), Ali Taher (American University of Beirut Medical Center), Swee Lay Thein, John F. Tisdale (National Heart, Lung, and Blood Institute), Suzy V. Torti (University of Connecticut Health Center), Tim M. Townes (The University of Alabama at Birmingham), Marsha J. Treadwell (Children's Hospital Oakland), Vip Viprakasit (Siriraj Hospital, Mahidol University), John C. Wood (Children's Hospital Los Angeles)

    Global experts explore the biology of globin gene regulation and fetal hemoglobin induction; stem cell transplant, gene therapy strategies, and gene editing; and clinical issues in thalassemia treatment and imaging.

    Tuesday, October 27, 2015 | 8:00 AM - 5:00 PM

    Phenotypic and Biomarker-Based Drug Discovery

    Speakers: Andras J. Bauer (Boehringer Ingelheim USA), Alex Huang (Genentech), Michael Jackson (Sanford-Burnham Medical Research Institute), Bryan Laffitte (Genomics Institute of the Novartis Research Foundation), Jonathan A. Lee (Eli Lilly), Lorenz Mayr (AstraZeneca), Friedrich Metzger (F. Hoffmann-La Roche Ltd), Bruce A. Posner (University of Texas, Southwestern Medical Center), Aravind Subramanian (Broad Institute), Giulio Superti-Furga (Austrian Academy of Sciences), Sue Swalley (Novartis Institutes for Biomedical Research)

    This symposium aims to deepen our understanding of phenotypic drug discovery and to foster the exchange of ideas between industry-based and academic research scientists.

    October 27 - December 5, 2015

    From Scientist to CSO: Experiencing the Scientific Method as your Guide to Career Success

    Course Instructors: Larry Petcovic (Human Workflows), Randall Ribaudo (Human Workflows)

    Enhance your communication, leadership, and teambuilding skills that all employers value by taking From Scientist to CSO, one of the most popular courses offered at the New York Academy of Sciences.

    October 28 - 29, 2015

    Pre-Approval Access: Can Compassion, Business, and Medicine Coexist?

    This 2-day colloquium will explore challenges surrounding pre-approval access to investigational medicines in a series of debates featuring prominent representatives of governments, pharmaceutical companies, patient groups, NGOs, and foundations.

    Tuesday, November 3, 2015 | 6:00 PM - 8:30 PM

    Grantsmanship for Postdocs

    Keynote Speaker: Jaime Rubin (Columbia University)

    Join Science Alliance and NYWiSTEM for the Grantsmanship workshop. During this evening seminar, Dr. Jaime Rubin will focus on best practices for effective grantsmanship, specifically applied to the NIH K99/R00 career transition grant application.

    Monday, November 16, 2015 | 6:30 PM - 8:30 PM

    Current Evidence on Non-caloric Sweeteners and their Health Implications

    Speakers: Kiyah Duffey (Virginia Tech), Gary D. Foster (Weight Watchers International, Inc), John Glendinning (Barnard College), Rick Mattes (Purdue University)

    This evening event will unpack current scientific research from multiple disciplines, regarding the effect of non-caloric sweeteners currently approved by the Food and Drug Administration for use in foods and beverages in the United States, on weight management and health.

    Thursday, November 19, 2015 | 8:30 AM - 5:15 PM

    Little Beans, Big Opportunities: Realizing the Potential of Pulses to Meet Today's Global Health Challenges

    Speakers: Vincent Amanor-Boadu (Kansas State University), Richard Black (PepsiCo), Laurette Dubé (McGill University), Corinna Hawkes (City University London), Allan Hruska (United Nations Food and Agricultural Organization), PK Joshi (International Food Policy Research Institute), Anna Lartey (United Nations Food and Agricultural Organization), Mark J Manary (Washington University School of Medicine in St Louis), Danielle Nierenberg (Food Tank), Sonny Ramaswamy (USDA National Institute of Food and Agriculture), K. Srinath Reddy (Public Health Foundation of India), John L. Sievenpiper (University of Toronto), Joanne Slavin (University of Minnesota)

    This inaugural conference will look at the role of pulses in healthy and sustainable diets, examine how pulses can make critical contributions to public health, and explore opportunities for enhancing these benefits broadly through food system innovations.

    Friday, December 4, 2015 | 8:30 AM - 6:00 PM

    Managing Disease-Related Lean Body Mass Loss through Clinical and Nutrition Interventions

    Speakers: David Evans (The Ohio State University), Gordon Jensen (The Pennsylvania State University), Robert Martindale (Oregon Health & Science University Healthcare), Peter A. McCullough (Dallas Baylor Heart and Vascular Hospital), Gerard Mullin (Johns Hopkins Medicine), Dennis H. Sullivan (University of Arkansas), Paul Wischmeyer (University of Colorado School of Medicine)

    Lean Body Mass Loss Clinical and Nutrition Interventions

    Tuesday, December 8, 2015 | 8:30 AM - 5:00 PM

    GLP-1 Treatment for Metabolic Disease and Beyond

    Speakers: David D'Alessio (University of Cincinnati), Matthew Hayes (Perelman School of Medicine, University of Pennsylvania), George Holz (State University of New York), Lotte Knudsen (Novo Nordisk), Patrick Sexton (Monash University), Konrad Talbot (Cedars-Sinai Medical Center)

    GLP-1 receptor agonists have improved treatment options in type 2 diabetes, although realizing their promise in other areas remains challenging. This symposium highlights preclinical and clinical breakthroughs and opportunities for drug development.